Search the Newsreel

Proficient Auto Logistics (NASDAQ: PAL) raises $75M notes and closes H&A deal

Proficient Auto Logistics (NASDAQ: PAL) successfully raised $75 million through an offering of 5.500% convertible senior notes due 2033 and completed its acquisition of Hansen & Adkins Auto Transport for approximately $130 million. This acquisition positions Proficient Auto Logistics as the largest auto hauler …

TuHURA Biosciences Expect Preliminary Results From IR Study IFX-2.0 With Keytruda for Deep Seated MCC in 1H2027 >HURA

TuHURA Biosciences anticipates preliminary results from its IFX-2.0 study, which combines IFX-2.0 with Keytruda for treating deep-seated Merkel Cell Carcinoma (MCC). These results are expected in the first half of 2027. This study represents a key milestone for TuHURA Biosciences in its development of …

Proficient Auto Logistics (NASDAQ:PAL) Director Acquires $217,200.00 in Stock

Proficient Auto Logistics (NASDAQ:PAL) Director Rohit Lal recently purchased 40,000 shares for $217,200 and an additional 10,000 shares for $55,300, significantly increasing his stake. The stock is trading near its 52-week low and below its moving averages. Analyst sentiment for PAL is mixed, with …

Rohit Lal Purchases 10,000 Shares of Proficient Auto Logistics (NASDAQ:PAL) Stock

Director Rohit Lal recently purchased 10,000 shares of Proficient Auto Logistics (NASDAQ:PAL) stock for $55,300, increasing his total holdings to 71,903 shares. This follows a previous purchase of 40,000 shares for $217,200. The stock is currently trading near its 52-week low, and analyst sentiment …

Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?

On August 11, Gilead Sciences, Inc. (NASDAQ:GILD) exercised its option to exclusively license a preclinical bispecific program targeting solid tumors using MacroGenics, Inc. (NASDAQ:MGNX)'s proprietary TRIDENT platform. The decision triggered a $10 million milestone payment to MacroGenics, injecting momentum into the companies' 2022 collaboration. …

Proficient Auto Logistics (PAL) President and COO purchases 995 shares at $5.55

Proficient Auto Logistics (PAL) CFO purchases 4,000 shares in open-market trade

Bright Minds Biosciences (NASDAQ:DRUG) Issues Quarterly Earnings Results

Bright Minds Biosciences (NASDAQ:DRUG) reported quarterly earnings per share of ($0.17), significantly surpassing analysts' consensus estimate of ($1.28). Following the announcement, shares fell 2.0% to $76.44. Analysts maintain a generally positive outlook on the stock, with an average "Buy" rating and a consensus price …

Proficient auto logistics COO Amy Rice buys $5,522 in stock

Amy F. Rice, COO of Proficient Auto Logistics, purchased 995 shares of the company's stock for $5,522, with the stock trading near its 52-week low. This purchase follows disappointing second-quarter financial results, where the company reported a revenue decline and an adjusted loss per …

Proficient auto logistics CFO buys $22,200 in stock

Proficient Auto Logistics CFO Bradley J. Wright purchased 4,000 shares of company stock for $22,200, at an average price of $5.55 per share, amidst a 25% decline in share price over the past week. This transaction increases his direct holdings to 70,200 shares. The …

Proficient Auto Logistics (PAL) director reports 50K-share open-market buy

Proficient Auto Logistics director Rohit Lal reported open-market purchases of 50,000 shares of the company's common stock. These transactions occurred on August 13 and August 14, 2026, with purchases made at weighted average prices of $5.43 and $5.53 per share, respectively. The filing indicates …

Boston Scientific (BSX) Stock Looks Cheap On Earnings And Fair Value

Is Castle Biosciences Inc (CSTL) a Bargain After 3.0% Drop? GF Value Says Undervalued

Castle Biosciences Inc (CSTL) shares recently dropped 3.0%, leading to a 7.5% decrease over the past week, but GuruFocus' GF Value indicates the stock is slightly undervalued. Despite a strong GF Score of 81/100, driven by high growth potential, the company faces significant challenges …

UBS Maintains Kodiak Sciences(KOD.US) With Buy Rating, Maintains Target Price $80

UBS has reiterated its Buy rating for Kodiak Sciences (KOD.US) and maintained its target price at $80. This indicates a continued positive outlook from the financial institution regarding the company's stock performance.

Perceptive Advisors (NASDAQ: SLDB) details 11.2% beneficial stake and warrant limits

Perceptive Advisors LLC and related entities, including Joseph Edelman, have reported a beneficial ownership of 12,046,579 shares in Solid Biosciences Inc. (NASDAQ: SLDB), representing an 11.2% stake. This includes common stock and pre-funded warrants, with the latter subject to a 9.99% beneficial ownership limitation …

TuHURA Biosciences (NASDAQ:HURA) Posts Earnings Results, Beats Estimates By $0.01 EPS

CSTL (CSTL) files notice to sell 24,908 common shares on NASDAQ

A holder of CSTL common stock has filed a notice of intent to sell up to 24,908 shares on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services. The indicated aggregate market value of these shares is $741,493.72, and they originated from restricted …

Pu’er Lancang Ancient Tea Sets Date to Approve Interim Results

Assembly Biosciences (ASMB) Stock Jumps As Losses Shrink And Revenue Builds

Is Boston Scientific (BSX) Still Undervalued After A 50% Fall?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Boston Scientific stock has fallen about 50% over the past year, yet valuation checks and an intrinsic value estimate based on a Discounted …

Alan Fournier's Bold Q2 2026 Move: Exiting Core Scientific Inc for a -4.6% Portfolio Impact

Alan Fournier, founder of Pennant Capital Management, made significant portfolio adjustments in Q2 2026, as revealed in his latest 13F filing. His most notable move was the complete liquidation of his Core Scientific Inc (NASDAQ:CORZ) stake, impacting his portfolio by -4.6%. Conversely, he initiated …

MCDONALDS CORP (MCD) president Anderson Skye details options, PRSUs and stock

Ciena Corp (CIEN) Stock Down 3.2% but Still Overvalued -- GF Sco

Ciena Corp (CIEN) shares recently dropped 3.2% to $428.77, yet GuruFocus assesses the stock as significantly overvalued with a GF Value™ of $99.71. The company has a GF Score™ of 72/100, indicating above-average performance with strong financial strength and growth, but a poor valuation …

Ciena (NYSE:CIEN) Stock Price Down 3.1% - Should You Sell?

Ciena (NYSE:CIEN) shares dropped 3.1% during mid-day trading, despite strong analyst sentiment with a "Moderate Buy" consensus and an average price target of $530.56. The company recently exceeded quarterly earnings expectations, reporting EPS of $1.64 against an expected $1.46 and revenue of $1.57 billion, …

Twist Bioscience Corp (TWST) Stock Down 5.4% but Still Overvalued -- GF Score: 69/100

Twist Bioscience Corp (TWST) shares dropped by 5.4% to $118.57, yet the stock is considered 126.4% overvalued compared to its GF Value™ of $52.38. Despite a strong growth rank of 10/10, the company's profitability and valuation ranks are low, coupled with significant insider selling …

Satellos Bioscience Sets Up US$50 Million U.S. At-the-Market Share Sales Facility

Alto Neuroscience (ANRO) investor group discloses 9.99% ownership cap

An investor group comprising Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. has reported a beneficial ownership of 9.99% in Alto Neuroscience (ANRO). This ownership, totaling 4,176,711 shares, includes common stock and pre-funded warrants, with the exercise of warrants capped …

Core Scientific Completes Acquisition of Polaris DS, Advancing Planned Muskogee Expansion to 1.5 GW of Gross Power

Core Scientific has announced the completion of its acquisition of Polaris DS LLC for approximately $444 million in cash, securing about 440 MW of gross power capacity. This acquisition advances Core Scientific's plan to expand its Muskogee campus to 1.5 GW of gross power, …

Inhibrx Biosciences (INBX) holders disclose 1.49M-share, 9.99% position

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 1,489,443 shares of Inhibrx Biosciences, Inc. (INBX) common stock, representing 9.99% of the class. This stake includes common shares and pre-funded warrants, with the exercise of …

Spruce Biosciences (SPRB): ADAR1, Schneeberger disclose 2.5% beneficial stake

ADAR1 Capital Management, LLC and Daniel Schneeberger have disclosed a 2.5% beneficial ownership stake in Spruce Biosciences, Inc. (SPRB) through a SCHEDULE 13G/A filing. This stake, totaling 67,717 shares, is held across various managed accounts, with both parties exercising shared voting and dispositive power. …

Valiant Capital discloses 5.3% Core Scientific (CORZ) position in amended 13G

Valiant Capital, along with its entities and Christopher R. Hansen, has disclosed a 5.3% beneficial ownership stake in Core Scientific (CORZ) through an amended Schedule 13G filing. This represents 16,956,009 shares of common stock, based on 321,340,441 shares outstanding as of July 23, 2026. …

Proficient Auto Logistics (PAL) Releases Q2 2026 Earnings: Revenue Declines and Loss Widens

Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors

Edwards Lifesciences Corp. (EW) stock fell 1.04% on Friday, closing at $91.60. This underperformance occurred on a generally negative trading day for the stock market, with both the S&P 500 Index and the Dow Jones Industrial Average also declining. The stock experienced its third …

Proficient Auto Logistics (PAL) widens loss and inks $130M H&A deal

Proficient Auto Logistics (PAL) reported a widened net loss of $10.4 million for the first half of 2026, compared to $4.7 million a year prior, with operating revenue slightly down to $203.1 million. Despite the loss, PAL closed a $130 million acquisition of Hansen …

TYRA Biosciences (TYRA) holder reports 3.55M-share, 6% beneficial stake

Ciena (CIEN) insider files to sell 2,500 shares after recent 10b5-1 sales

An insider at Ciena Corporation (CIEN), David Rothenstein, has filed a Form 144 to sell 2,500 shares of common stock, valued at $1,106,975.00. These shares are related to Restricted Stock Units from 2021. The filing also notes previous 10b5-1 plan sales of 2,500 shares …